TAMPA, Fla., Oct. 14, 2026 /PRNewswire/ -- Third Lake Development announced that Jamie Telchin has joined the firm as President of Multifamily, where he will oversee the continued growth and execution of the Third Lake Development's multifamily platform. Jamie Telchin brings more than 25 years of real estate development experience and has led the development and redevelopment of projects representing approximately $3 billion in total capitalization across multiple asset classes, including multifamily, luxury residential, hospitality, medical and mixed-use developments.

In his role, Jamie Telchin will be responsible for advancing Third Lake Development's multifamily strategy, including sourcing new development opportunities, guiding projects through entitlement and development, and helping expand the firm's presence in high-growth markets throughout the Sun Belt.

"We are excited to welcome Jamie to Third Lake Development," said Luke Thomas, Chief Executive Officer of Third Lake Development. "His depth of experience, leadership and track record of delivering complex projects will be instrumental as we continue to grow our multifamily platform. Jamie's strategic perspective and development expertise make him an exceptional addition to our team."

Prior to joining Third Lake Development, Jamie Telchin held senior leadership positions with several prominent real estate organizations, most recently serving in multifamily development leadership roles focused on expanding multifamily platforms across the Sun Belt.

"I am excited to join Third Lake Development at such an exciting stage of the firm's growth," said Jamie Telchin. "Third Lake Development has built a strong reputation for identifying compelling opportunities and executing high-quality developments. I look forward to working alongside the team to expand the multifamily platform and continue creating communities to meet the ongoing need for multifamily housing across the nation while generating long-term value for our partners."

The addition of Jamie Telchin further strengthens Third Lake Development's leadership team as the firm continues to expand its multifamily, build-to-rent and self-storage platforms across the Sun Belt.

ABOUT THIRD LAKE DEVELOPMENT

Third Lake Development, LLC is a vertically integrated real estate development company specializing in ground-up multifamily, build-to-rent, self-storage and mixed-use projects in high-growth markets. The firm focuses on data-driven site selection, institutional-quality design and disciplined capital execution to deliver long-term value for partners and communities.

www.thirdlakedevelopment.com 

CONTACT

Jennifer Carvalho

[email protected]

SOURCE Third Lake Development

Share this article

California Science Center Members receive early reservation access beginning October 19

Clickherefor images and footage

Clickherefor archival images and footage

LOS ANGELES, Oct. 14, 2026 /PRNewswire/ -- The California Science Center announced today that advance reservations for the Samuel Oschin Air and Space Center, the permanent home of Space Shuttle Endeavour, will be available beginning Wednesday, October 21, 2026, at 9:30 a.m., ahead of the new Air and Space Center's public opening on Friday, November 13.

California Science Center Members will receive early access to reservations beginning Monday, October 19, at 9:30 a.m.

"Fourteen years after Space Shuttle Endeavour arrived at the California Science Center, following its incredible overland journey across Los Angeles and Inglewood, reservations will soon become available to see it in its permanent home this November," said President and CEO of the California Science Center, Jeffrey Rudolph. "The Samuel Oschin Air and Space Center fulfills a decades-long dream and provides us with our biggest platform yet to stimulate curiosity and inspire science learning in everyone."

The Samuel Oschin Air and Space Center is a 200,000-square-foot expansion of the California Science Center that will nearly double the museum's exhibit space. The new center features more than 100 artifacts, including rare and historic aerospace objects, along with 100 new hands-on exhibits, featuring interactive experiences focused on science, technology, and engineering. The three multi-level galleries – the Samuel Oschin Shuttle Gallery, the Korean Air Aviation Gallery, and the Kent Kresa Space Gallery – represent the third and final phase of a three-decade master plan to develop one of the world's leading science learning centers. At the heart of the new center, Space Shuttle Endeavour will be displayed vertically in a launch-ready configuration with authentic solid rocket boosters and the last remaining flight-qualified external tank, ET-94. The Samuel Oschin Air and Space Center opens to the public on Friday, November 13, 2026, at 10:00 a.m.

RESERVATION DETAILS

Advance reservations will be available at: https://californiasciencecenter.org/visit/get-reservations-tickets or by calling 213-744-2019. Guests can make up to 19 individual reservations per entry time. Parties of 20 or more individuals require a group reservation by calling 213-744-2019.

While general admission to the California Science Center is free, reservations for the Samuel Oschin Air and Space Center – including Space Shuttle Endeavour – are strongly encouraged due to anticipated high demand. Entry may be limited for visitors without advance reservations. A $4 reservation service fee per person will apply; the fee will be waived for California Science Center Members.

Membership to the California Science Center Foundation supports a world-class educational resource and family destination that is available to everyone, general admission free. All Memberships are family memberships and include program and event admission for up to two adults and four children (aged 17 and under). Several Membership levels are available, with additional benefits and experiences varying by gift level. In appreciation for their support, California Science Center Members will be eligible to make the first reservations beginning October 19 at 9:30 a.m.

More information about California Science Center Membership can be found at californiasciencecenter.org/member.

About the California Science Center

The California Science Center is a dynamic destination where families, adults, and children can explore the wonders of science through hands-on exhibits, live demonstrations, innovative programs, and awe-inspiring large-format movies. The California Science Center and IMAX Theater are located in historic Exposition Park just west of the Harbor (110) Freeway at 700 Exposition Park Drive, Los Angeles. Open daily from 10:00 a.m. to 5:00 p.m. General admission to the Science Center is FREE. The California Science Center is proud to be accredited by the Association of Zoos and Aquariums (AZA) and the American Alliance of Museums (AAM). Visit https://californiasciencecenter.org/ for more information.

About the EndeavourLA Campaign

A project of this scope and scale requires the visionary leadership of the philanthropic community and the support of the broader public. EndeavourLA is the California Science Center Foundation's fundraising campaign that enabled the acquisition and previous temporary display of space shuttle Endeavour supports our work to complete the Samuel Oschin Air and Space Center and sustain ongoing exhibits, programs, and operations. The project's lead donors are the Mr. and Mrs. Samuel Oschin Family Foundation and the State of California, joined by principal donors Korean Air and the Kresa Family Foundation, along with numerous individuals, foundations, and corporate supporters. 

The California Science Center Foundation is actively fundraising to complete this ambitious project, with over $415 million raised toward the $450 million goal. Everyone can help realize this exciting vision for the future Samuel Oschin Air and Space Center, and donations at any level are welcome. To contribute or learn more, go to endeavourla.org.

About Membership to the California Science Center

For more information about opportunities to support the California Science Center Foundation as a Member visit our website at californiasciencecenter.org/member, email [email protected] or call 213-744-7504. Memberships can be purchased online or in person at the Membership Services Window, located at the Box Office, open daily from 10:00 a.m. to 4:30 p.m.

Media Contacts

Kristina Kurasz Cutting | Director of Communications | California Science Center

[email protected] | 213-744-7446

Sophie Jefferies | Communications Manager | California Science Center

[email protected] | 213-744-7491

Maura Klosterman-Vu | Polskin Arts

[email protected] | 310-552-4117

SOURCE California Science Center Foundation

Share this article

First-of-its-kind, seven-year agreement brings Hadrian's automated manufacturing capabilities directly into Lockheed Martin's Grand Prairie facility to scale critical missile production

TORRANCE, Calif., Oct. 14, 2026 /PRNewswire/ -- Hadrian, the advanced manufacturing company building highly automated factories and production capacity for America, today announced a first-of-its-kind, seven-year agreement with Lockheed Martin to bring Hadrian's advanced manufacturing capabilities directly into Lockheed Martin's Missiles and Fire Control (MFC) facility in Grand Prairie, Texas.

Building on the memorandum of understanding announced in December 2025, the agreement will integrate Hadrian's manufacturing capabilities, Opus software platform, and national factory network with Lockheed Martin's program and production expertise. Together, the companies will add scalable manufacturing capacity to support critical missile programs integral to the United States' Arsenal of Freedom, including PAC-3 MSE, THAAD, PrSM, and GMLRS.

Through the partnership, Hadrian and Lockheed Martin will:

- Add advanced manufacturing capacity at Lockheed Martin's Grand Prairie facility to support production across key missile programs.

- Strengthen supply chain resiliency by bringing machining capacity on-site while maintaining access to Hadrian's broader manufacturing network.

- Combine Hadrian's Opus software and automated manufacturing capabilities with Lockheed Martin's existing program and production expertise.

- Begin commissioning in early 2027, with manufacturing cells phased in over the seven-year agreement and each supporting multiple missile programs.

"The warfighter can't wait on peacetime timelines. Hadrian is bringing the automation, software, and workforce training from our own factories directly into Lockheed Martin, so we can produce more, faster. Rebuilding the Arsenal of Freedom at the scale America needs will take partnerships that combine expertise and speed, and this is what that looks like," said Chris Power, CEO of Hadrian.

Hadrian will operate directly inside Lockheed Martin's production ecosystem in Grand Prairie, creating a new model for expanding domestic capacity needed to produce critical defense systems. The partnership will also provide the flexibility to shift production across Hadrian's broader machining network as demand evolves.

"Moving with wartime urgency to deliver the combat-proven capabilities the United States and our allied partners need at unprecedented scales requires innovative solutions and thinking differently," said Tim Cahill, president, Lockheed Martin Missiles and Fire Control. "This partnership brings together the world-class workforce and proven excellence of Lockheed Martin with Hadrian's expertise in commercial technology, ensuring we take the best of both companies to meet the mission."

The partnership is designed not only to meet today's production needs, but to strengthen the American manufacturing base needed to sustain U.S. defense production for the long term.

About Hadrian

Hadrian is rebuilding America's industrial base with highly automated factories that combine process engineering, AI, and robotics. Its mission is to help space and defense manufacturers produce full programs at scale in the U.S. while giving American workers the tools to compete globally.

The company operates four facilities covering just under 3 million square feet: two in Torrance, California, and newly launched sites in Arizona and Alabama, with additional sites in development across the country. More information at https://www.hadrian.co/.

About Lockheed

Lockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready. More information at Lockheedmartin.com.

Media Contact: [email protected]

SOURCE Hadrian

Share this article

New initiative will engage the next generation of dermatology leaders to advance research, patient education, and innovation in skin health.

NEW YORK, Oct. 14, 2026 /PRNewswire/ -- American Skin Association (ASA) is pleased to announce the formation of the American Skin Association Emerging Dermatology Leaders Advisory Committee, a new initiative designed to engage and cultivate the next generation of leaders in dermatology. The committee will provide guidance on emerging research priorities, pipeline therapies, unmet needs in dermatologic care, current trends in skin health, and innovative approaches to patient education and community outreach.

The committee reflects ASA's continued commitment to ensuring that emerging scientific advances, clinical perspectives, and patient needs remain central to the organization's work. For nearly four decades, ASA has served as a leading nonprofit organization dedicated to advancing research, championing skin health, particularly among children, and raising public awareness about skin disease. ASA has awarded more than $50 million in research grants to advance treatments and the search for cures for melanoma, vitiligo, psoriasis, atopic dermatitis, hidradenitis suppurativa, and other serious skin diseases.

"The ASA Emerging Dermatology Leaders Advisory Committee represents an important investment in the future of dermatology and in the continued growth of ASA," said Howard P. Milstein, Chairman of ASA. "These physicians bring a breadth of expertise, energy, and new perspectives that will be valuable as ASA considers emerging areas of research, advances in patient care, and new ways to educate and engage the public."

Nicholas Brownstone, MD, Assistant Professor of Dermatology at the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, NY, will serve as Chair of the committee.

Dr. Brownstone brings broad experience in clinical dermatology, research, and medical education, with a background in both medical and cosmetic dermatology. His research experience includes psoriasis, phototherapy, eczema, hidradenitis suppurativa, psychodermatology, and skin cancer, and he has published in peer-reviewed medical journals and textbooks and presented at national dermatology conferences. He has also served as a host for ASA's podcast series, The SKINsight Podcast: A Patient's Guide.

"As dermatology continues to evolve at an extraordinary pace, there is an important opportunity to bring the perspectives of the next generation of physicians into conversations about where the field is headed," said Nicholas Brownstone, MD. "This committee will allow emerging leaders to work closely with ASA's Board and leadership to identify important scientific opportunities, address unmet needs in patient care and education, and contribute new ideas that can help strengthen ASA's impact for patients and families."

The committee's six founding members, alongside Dr. Brownstone, represent a broad range of expertise across dermatology:

- Benjamin Ungar, MD, is Director of the Alopecia Center of Excellence and Director of the Rosacea & Seborrheic Dermatitis Clinic at the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai. His clinical and research work focuses on inflammatory and hair disorders, including alopecia areata, rosacea, and seborrheic dermatitis.

- Helen He, MD, is Assistant Professor in the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai, Director of Lasers and Cosmetic Surgery, and Co-Director of the Mount Sinai-Clinique Healthy Skin Dermatology Center. She specializes in cosmetic and medical dermatology and has a translational research background in inflammatory skin diseases and skin aging.

- Nicholas Gulati, MD, PhD, is Assistant Professor of Dermatology, Director of the Early Detection of Skin Cancer Clinic at the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center, and Director of the Oncodermatology Clinic at Mount Sinai. His clinical focus includes melanoma and other skin cancers, and his work encompasses early detection as well as dermatologic care for patients experiencing skin conditions associated with cancer treatment.

- Ahuva Cices, MD, is Director of the Cutaneous Manifestations of Inflammatory Bowel Disease Clinic and Director of Cosmetic Dermatology for Patients with Autoimmune Disease at the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai. She practices both medical and cosmetic dermatology with clinical experience spanning a broad range of skin conditions, including autoimmune and inflammatory diseases, and has served as an investigator in numerous clinical trials.

- Prince Adotama, MD, is Assistant Professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, Associate Director of the Undergraduate Curriculum in Dermatology, and Assistant Program Director of the Dermatology Residency Program. His clinical and research work includes skin of color, hair disorders, autoimmune skin disease, and health disparities, as well as medical education.

- Michael Lor, MD, is Assistant Professor of Clinical Dermatology at Weill Cornell Medical College. His clinical practice encompasses general and complex medical dermatology, with experience caring for patients with a wide range of dermatologic conditions, including inflammatory skin diseases, infections, skin cancer, and cutaneous lymphoma. He has demonstrated a strong commitment to medical education and has received recognition for his contributions to teaching and humanism in medicine.

Together with Dr. Brownstone, the founding members will advise ASA leadership on scientific expansion and pipeline therapies, including emerging areas such as alopecia areata, hidradenitis suppurativa, vitiligo, inflammatory skin diseases, skin cancer, and aging skin. Members will also help identify unmet needs in dermatology research and education and provide input on opportunities to strengthen ASA's grant and research initiatives.

"ASA has a long history of bringing together patients, physicians, scientists, and advocates to advance the field of dermatology," said James G. Krueger, MD, PhD, President of ASA. "This new committee builds on that tradition by creating a dedicated forum for emerging leaders to share their perspectives and help inform the scientific and educational priorities that will shape dermatology in the years ahead."

The formation of the ASA Emerging Dermatology Leaders Advisory Committee underscores ASA's commitment to remain at the forefront of scientific innovation and community engagement while cultivating the next generation of leaders in dermatology. By connecting emerging physician leaders with ASA's established network of scientists, physicians, and advocates, the initiative aims to strengthen the organization's ability to advance research, expand education, and improve the lives of people affected by skin diseases.

ABOUT AMERICAN SKIN ASSOCIATION

A unique collaboration of patients, families, advocates, physicians, and scientists, ASA has evolved over nearly four decades as a leading force in efforts to defeat melanoma, vitiligo, psoriasis, atopic dermatitis, and other skin diseases. Established to serve the now more than 100 million Americans — one-third of the U.S. population — afflicted with skin disorders, the organization's mission remains to: advance research, champion skin health, particularly among children, and drive public awareness about skin disease. ASA is a 501(c)3 nonprofit organization. For more information, visit americanskin.org. 

American Skin Association has earned Candid's 2026 Seal of Platinum Transparency and the Four-Star Rating from Charity Navigator.

SOURCE American Skin Association

Share this article

The Article Explains How Statements to Insurance Companies Can Affect Accident Claims and Why Careful, Accurate Answers Matter

ROLLA, Mo., Oct. 14, 2026 /PRNewswire/ -- What should you know before giving an insurance company a statement? HelloNation published an article featuring insights from Bryce C. Crowley of Steelman Gaunt Crowley that answer this question.

The HelloNation article explains that an insurance company may contact someone soon after a car accident to gather information. An insurance adjuster may ask basic questions or request a recorded statement about the collision. The article notes that anything said during that conversation can become part of the insurance claim record.

A recorded statement is typically a question-and-answer conversation kept in the insurer's claim file. According to the article, questions may address the accident location, vehicle movements, injuries, medical treatment, and prior health conditions. Because those answers can influence how an insurance claim is evaluated, accuracy matters.

The article advises people not to guess when they do not know or remember a detail. Estimates about speed, distance, timing, or another driver's actions can introduce information that may be difficult to correct later. Personal Injury Attorney Bryce C. Crowley's insights are featured in the article, which explains why factual answers can help maintain an accurate claim record.

Questions about injuries also require care after a car accident. The article notes that some symptoms may not appear until hours or days after the collision. Accurately describing current symptoms is more appropriate than predicting recovery time or whether additional medical treatment will be needed.

The HelloNation article also distinguishes between requests from different insurance companies. A person's own policy may require cooperation with their insurer during an accident investigation. A request from the other driver's insurance company involves a different relationship and should be considered accordingly before providing a recorded statement.

The article explains that an insurance adjuster may use a friendly, conversational approach while gathering information. However, the discussion still has a business purpose involving coverage, liability, injury claims, and damages. Even an informal conversation may later matter when the insurance company reviews the claim.

The article also advises caution when discussing fault. Drivers may see only part of a collision as it happens, while photographs, police reports, witnesses, and vehicle damage can provide additional information. Stating what is known instead of assuming what happened can help avoid unsupported conclusions.

Before speaking with an insurer, the article suggests reviewing basic accident information. This may include the date and location, vehicles involved, photographs, and notes made after the collision. Reviewing known facts can reduce confusion and help a person provide clear information without rehearsing or exaggerating.

The article concludes that giving a statement is more than an informal discussion about a car accident. The information provided may influence decisions about fault, coverage, injury claims, and compensation. By understanding who is requesting information and why, readers can better appreciate the importance of an accurate insurance claim record and the guidance that Personal Injury Attorney Bryce C. Crowley discusses.

What to Know Before Giving an Insurance Company a Statement features insights from Steelman Gaunt Crowley's Bryce C. Crowley, a personal injury attorney in Rolla, Missouri, in HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative "edvertising" approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article

NASDAQ | TSX: ACB

- Revised Hostile Bid continues to significantly undervalue Aurora; fails to address concerns previously raised by the Board.

- Aurora's Special Committee is actively exploring strategic alternatives to maximize value for Aurora shareholders.

- Shareholders are advised to REJECT the revised Hostile Bid and TAKE NO ACTION at this time before other strategic alternatives may emerge.

- Questions about the Hostile Bid or would like to stay informed? Contact Kingsdale Advisors toll-free at 1-800-749-9052 within North America, call or text 416-623-4172 or email [email protected].

EDMONTON, AB, Oct. 14, 2026 /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on the unanimous recommendation of a special committee of independent directors (the "Special Committee"), unanimously recommends that shareholders REJECT the hostile offer by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) for all of the issued and outstanding common shares of the Company, as revised in the Notice of Variation, Change and Extension filed by Curaleaf on October 6, 2026 (the "Hostile Bid").

"Curaleaf's revised offer still does not reflect the value of the company Aurora shareholders own today. Aurora is debt-free with a strong cash position, and we believe the revised Hostile Bid continues to ask shareholders to give up that strength, and their future upside, at a discount," said Miguel Martin, Executive Chairman and CEO of Aurora.

"At the same time, our Special Committee is carefully evaluating strategic alternatives with the goal of delivering greater value for Aurora shareholders. Curaleaf's offer remains open until December 4, 2026, so we believe shareholders gain nothing by tendering now, and tendering early could undermine the opportunity for a superior outcome. We urge shareholders to keep their options open, reject the revised Hostile Bid and take no action until they can consider all the alternatives available to them," concluded Mr. Martin.

The Board's determination follows careful consideration of, among other things, advice from its financial and legal advisors, including an updated inadequacy opinion from its financial advisor, and the unanimous recommendation of the Special Committee. To reject the revised Hostile Bid, simply TAKE NO ACTION. Shareholders who have tendered their Aurora shares and wish to withdraw, are advised to contact their broker or contact Kingsdale Advisors to assist with this process.

A Notice of Change to Directors' Circular (the "Notice of Change") providing the full details concerning the Board's recommendation, including the reasons to REJECT the revised Hostile Bid and additional details in respect of the ongoing strategic alternatives process, will be made available on the Company's special website at www.ProtectAurora.com, on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov. The principal reasons for the Board's recommendation to reject the revised Hostile Bid will be detailed in the Notice of Change and include:

- The revised Hostile Bid remains inadequate and significantly undervalues Aurora on several measures. The Board and Special Committee have received an updated fairness opinion from their financial advisor confirming that the revised consideration is inadequate, from a financial point of view, to Aurora shareholders.

- Curaleaf continues to propose to use Aurora Shareholders' own cash to acquire control of Aurora without paying fairly. A significant portion of the cash consideration would, in effect, be funded by the Aurora Shareholder's own cash through Aurora's balance sheet.

- Aurora Shareholders bear the risk. The increase in consideration consists principally of Curaleaf shares at an inflated valuation; Aurora shareholders would remain fully exposed to any decline in the Curaleaf share price.

- The Hostile Bid remains opportunistic. It seeks to acquire Aurora's assets at a discount and does not reflect the longer-term earning power of Aurora's global business.

- Curaleaf has not adequately supported its estimated synergies. Even if the synergies were realized, substantially all of the benefit would accrue to Curaleaf's existing shareholders and not Aurora shareholders.

- Superior proposals or other alternatives may emerge from Aurora's ongoing strategic review process. Aurora shareholders are encouraged to wait for the results of that process. Tendering into the Hostile Bid could negatively affect the possibility of a superior alternative being available for Aurora shareholders to consider.

Update on Strategic Alternatives Process

The Special Committee, with the assistance of its and the Company's financial and legal advisors, is actively exploring a range of alternatives to the revised Hostile Bid that may offer shareholders greater value than the revised Hostile Bid. These alternatives include, among other things, a possible transaction with one or more third parties or remaining independent and pursuing Aurora's existing strategy as a stand-alone entity.

The Special Committee, through the Company's financial advisor, has solicited a number of parties to ascertain their interest in Aurora. Aurora has entered into confidentiality and standstill agreements with multiple parties, each of whom have been examining information relating to Aurora. Aurora has had numerous discussions with these parties. As this process is ongoing, it is not possible at this time to predict with certainty what alternatives (if any) may emerge from this process. There can be no assurance that the process will result in a transaction. However, shareholders should not tender their shares until the process is completed.

The Board and the Special Committee believe that it is in the best interests of Aurora and its shareholders for there to be sufficient time to permit strategic alternatives that may be available to Aurora to emerge, and for the Special Committee to review and evaluate such potential alternatives. After the Special Committee and the Board have had the opportunity to explore, pursue and evaluate alternatives, the Board intends to provide a further recommendation to shareholders. Tendering into the revised Hostile Bid prematurely could negatively affect the possibility of a superior alternative being available for shareholders to consider.

Shareholder Assistance

Aurora shareholders with questions about the revised Hostile Bid or who would like to stay informed may contact Kingsdale Advisors, the Company's strategic advisor and information agent:

- Toll-Free (within North America): 1-800-749-9052

- Call or Text: 416-623-4172

- Email: [email protected]

- Visit www.ProtectAurora.com

About Aurora Cannabis

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.

Learn more at www.auroramj.com and follow us on X and LinkedIn.

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Aurora has filed a Solicitation/Recommendation Statement on Schedule 14D-9F with the U.S. Securities and Exchange Commission (the "SEC"), which includes a Directors' Circular, dated September 1, 2026, as amended by the Notice of Change. Investors are urged to read this document and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, when they become available, before making any investment decision with respect to the Hostile Bid. The Hostile Bid is made for the securities of a Canadian issuer and while the Hostile Bid is subject to disclosure requirements of Canada, investors should be aware that these requirements are different from those of the United States. The enforcement by investors of civil liabilities under the U.S. federal securities laws may be affected adversely by the fact that the issuer is located in Canada, and that some or all of its officers and directors are residents of Canada.

Forward-Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements and information regarding the Company's strategy and opportunities for creating and increasing long-term value for shareholders, the Special Committee's strategic alternatives process and the potential outcomes thereof, and expected impacts for Aurora shareholders.

These forward-looking statements are only predictions. Forward-looking information or statements contained in this news release have been developed based on the Company and its management's good faith assumptions relating to the financial, market, regulatory and other relevant environments that will exist and affect the Company's business and operations in the future.

"Beneath the Spanish Sky" Gala on May 1, 2027 to Honor Dr. Raj Bhatia and David Edsall with the Catherine McAuley Lifetime Achievement Award

VENTURA COUNTY, Calif., Oct. 14, 2026 /PRNewswire/ -- St. John's Healthcare Foundation will host its 2027 Signature Gala, Adventure, on Saturday, May 1, 2027, at the Four Seasons Hotel Westlake Village. This year's Spain-inspired celebration, themed "Beneath the Spanish Sky: Rhythm, Recognition and Rich Tradition," will bring together community leaders, physicians and supporters for an evening benefiting St. John's Cancer Services.

Beginning at 4:30 p.m., the black-tie event will feature a reception with tasting stations, a multi-course culinary experience, wine, entertainment and silent and live auctions. One hundred percent of funds raised during the gala will support Cancer Services, helping St. John's continue and expand access to cancer care throughout Ventura County, including advanced imaging technology, infusion treatments and oncology services.

"Adventure is an opportunity for our community to come together in celebration while supporting care that has a direct and lasting impact on patients and families throughout Ventura County," said Heather Huffman, Vice President of Philanthropy for St. John's Healthcare Foundation. "The generosity of our sponsors and guests helps ensure that patients can continue to access the cancer services and resources they need close to home."

The 2027 gala will honor Dr. Raj Bhatia and David Edsall with the Catherine McAuley Lifetime Achievement Award, which recognizes individuals whose service and leadership reflect a lasting commitment to the community and the mission of St. John's Hospitals.

Dr. Bhatia has served patients throughout the region for more than two decades and is board-certified in Internal Medicine, Critical Care Medicine, Pulmonary Disease and Sleep Medicine. Dr. Bhatia serves as the Medical Director of St. John's ICU/CCU department, and for a decade, devotes his time as a board member of the St. John's Healthcare Foundation. Dr. Bhatia's leadership at St. John's Hospitals has made a lasting impact through his commitment to patient care and medical leadership.

David Edsall, founding partner of Edsall Law in Camarillo, has more than 35 years of experience in estate planning and civil law. He has also served St. John's Hospitals as a Foundation Board Member for more than 12 years, including as past Chair of the St. John's Healthcare Foundation Board.

"It is incredibly meaningful to be part of Adventure and to recognize two people who have given so much to St. John's and the Ventura County community," said Jonathan Davis, St. John's Healthcare Foundation Board Vice Chair and Adventure Event Committee member. "This event brings the community together around an important purpose while celebrating the service and leadership of Dr. Bhatia and David Edsall."

The 2027 Adventure Event Committee includes Nancy Borchard, Lindsey Carnett, Harriet Friedman, Kim Gibas, Diane Off, Lisa Grace, Nayelly Davis, Tony Murguia, Laura Alvarez, Patty Paumier, Joyce Resnik and Katherine E. Wells.

St. John's Cancer Services have expanded throughout Ventura County and include hematology-oncology, general surgery, the Cancer Resource Center and Integrated Breast Center, infusion centers in Camarillo, Oxnard and Ventura, and radiation oncology. Cancer Center locations include St. John's Regional Medical Center in Oxnard and St. John's Hospital Camarillo.

Sponsorship opportunities for the 2027 Adventure Gala range from $2,500 to $25,000, with individual seats available for $450 and tables of 10 available for $4,500. For sponsorship and reservation information, visit https://www.supportstjohns.org/adventure-2027 , email [email protected]or call (805) 988-2868.

About St. John's Healthcare Foundation

St. John's Healthcare Foundation is a non-profit 501(c)(3) organization established in 1985 that raises philanthropic support for St. John's Regional Medical Center in Oxnard, California and St. John's Hospital Camarillo in Camarillo, California, both part of CommonSpirit Health®.

Press Contact:

Name: Frank Tortorici

Email: [email protected]

SOURCE St. John's Healthcare Foundation

Share this article

PHILADELPHIA, Oct. 14, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP represented Brandywine Realty Trust (NYSE: BDN) in the disposition of a 441,000-square-foot office building in Philadelphia to Burlington Stores (NYSE: BURL).

Located at 3151 Market St. in Philadelphia's University City neighborhood, the building will serve as the new corporate headquarters for Burlington. The retailer plans to occupy the entire building and relocate its headquarters from New Jersey, bringing an estimated 2,000 new jobs to Philadelphia over the next five years.

The Greenberg Traurig deal team was led by Shareholders Joshua D. Cohen and David B. Lipner, with assistance from Associate Aska Fujimori-Smith and Paralegal Rebecca Jaegers. Complex components of the transaction required significant interdisciplinary support, with meaningful contributions across the Greenberg Traurig platform, including by Shareholders Michael A. Suleta and Timothy W. Donovan, Of Counsels Laura Bottaro Galier and Brian L. Gaudet, and Associate Laura Hendee Siman.

"We deeply appreciate and value our relationship with longtime client and close partner Brandywine and congratulate them on this significant achievement," PhiladelphiaReal Estate Practice Chair Cohen said. "We also applaud the Burlington team and our local and state officials, including Gov. Josh Shapiro and Mayor Cherelle Parker, for their leadership in this game-changing move for the city and the commonwealth."

"It was a privilege to work alongside Brandywine, whose strategic vision in Schuylkill Yards is transforming growth in our city," Lipner added. "As a Philadelphia real estate attorney, it's especially rewarding to work on a transaction that will have such a lasting impact on the city's future. Its successful execution reflects the strength of Greenberg Traurig's national platform. The Greenberg Traurig team included attorneys across practices and offices, enabling us to provide integrated counsel on every aspect of the transaction."

"Greenberg Traurig is a trusted and valued partner of Brandywine," Brandywine Senior Vice President, General Counsel, and Secretary Shawn Neuman said. "Their deal-oriented approach, sound judgment, and bench of attorneys with expertise spanning the spectrum of real estate matters have been instrumental to our achievement of transactional objectives."

About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.

SOURCE Greenberg Traurig, LLP

Share this article

BSR REIT to Report Third Quarter 2026 Financial Results on November 11, 2026

LITTLE ROCK, Ark. and TORONTO, Oct. 14, 2026 /PRNewswire/ -- BSR Real Estate Investment Trust (the "REIT") (NYSE: BSRT) (TSX: BSRT.UN) announced today that it will release its 2026 third quarter financial results after market close on Wednesday November 11th, 2026.

Dan Oberste, Chief Executive Officer, and Tom Cirbus, Chief Financial Officer, will host a conference call for analysts and investors on Thursday, November 12th, 2026 at 12:00 pm (ET). To join the conference call without operator assistance, participants can register and enter their phone number at: https://registrations.events/easyconnect/8251191/recCMVM1vWt2zEC00/ to receive an instant automated call back. Alternatively, they can dial 647-932-3411 or 800-715-9871 to reach a live operator who will join them into the call. In addition, the call will be webcast live at: https://app.webinar.net/Z86l4kv2LWp.

A replay of the call will be available until Thursday, November 19th, 2026. To access the replay, dial 647-362-9199 or 800-770-2030 (Code: 8251191#). A transcript of the call will be archived on the REIT's website.

About BSR Real Estate Investment Trust

BSR Real Estate Investment Trust is an internally managed, unincorporated, open-ended real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario. The REIT owns a portfolio of multifamily garden-style residential properties located in attractive primary and secondary markets in the Sunbelt region of the United States.

SOURCE BSR Real Estate Investment Trust

Share this article

The article outlines key differences in underground utility installation methods and their impact on Albany construction projects.

ALBANY, N.Y., Oct. 14, 2026 /PRNewswire/ - What is the best way to install underground utilities without disrupting busy city environments? HelloNation published an article that answers this question, featuring insights from Construction Expert David Allegretta of JAT Construction in Albany.

The HelloNation article explains the differences between trenchless drilling and traditional excavation, two common approaches used in Albany construction and other urban infrastructure work. Traditional excavation involves digging open trenches to access underground utilities such as pipes and cables. While effective, the article notes that this method can disrupt roads, sidewalks, and surrounding infrastructure, often leading to delays and added costs in active construction projects.

In contrast, trenchless drilling offers a less invasive solution. The article explains that this method uses specialized equipment to create underground pathways without large trenches. This approach allows construction projects to move forward while minimizing disruption to traffic, businesses, and public spaces. For cities like Albany, where infrastructure is dense and space is limited, trenchless drilling provides a practical alternative.

The article highlights that trenchless drilling is particularly useful in areas with heavy vehicle and pedestrian traffic. By avoiding extensive digging, contractors can maintain normal above-ground activity while work continues below. This advantage is especially important throughout the Hudson Valley, the Capital Region, Upstate, Central, and Western New York construction, where maintaining accessibility and minimizing inconvenience are key priorities.

Construction Expert insights featured in the article emphasize that traditional excavation still has its place. The article explains that for simpler projects or areas with fewer surface constraints, traditional excavation may be a suitable and cost-effective option. However, as infrastructure becomes more complex, trenchless drilling is often preferred for its efficiency and reduced impact.

The article also explores specific trenchless drilling techniques, including horizontal directional drilling, pipe bursting, and microtunneling. Each method serves different purposes within underground utilities installation and repair. Horizontal directional drilling is commonly used for installing pipelines and cables beneath obstacles, while pipe bursting is effective for replacing aging infrastructure. These methods allow crews to complete construction projects with greater precision and less surface damage.

Another key point the article covers is cost. While trenchless drilling may cost more upfront than traditional excavation, the article notes that overall savings often come from reduced labor, shorter timelines, and less need for restoration. In Albany construction, where restoring roads and landscapes can be expensive, this efficiency can make a significant difference.

The HelloNation article also explains that trenchless drilling reduces the risk of damaging existing underground utilities. With traditional excavation, there is a higher risk of accidentally disrupting other lines, leading to delays and additional repairs. By using controlled drilling methods, contractors can better navigate complex infrastructure systems.

Environmental considerations are also addressed. The article explains how trenchless drilling reduces soil disturbance and preserves existing landscapes, making it a more environmentally responsible choice for many construction projects. This benefit aligns with growing expectations for sustainable practices in modern infrastructure development.

Ultimately, the article concludes that the decision between trenchless drilling and traditional excavation depends on project needs, location, and budget. Understanding these methods helps construction teams choose the most effective approach for installing and maintaining underground utilities while balancing cost, efficiency, and impact.

Trenchless Drilling vs Traditional Excavation Explained features insights from David Allegretta, a construction expert in Albany, New York, on HelloNation.

About HelloNation

HelloNation is a premier media platform that connects readers with trusted professionals and businesses across various industries. Through its innovative "edvertising" approach that blends educational content with storytelling, HelloNation delivers expert-driven, good-news articles that inform, inspire, and empower. Covering topics from home improvement and health to business strategy and lifestyle, HelloNation highlights leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article